{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:07:27Z","timestamp":1789063647511,"version":"build-2803163510"},"reference-count":30,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000415","name":"Northern Ireland Chest, Heart and Stroke Association","doi-asserted-by":"publisher","award":["Grant award number 2018_03"],"award-info":[{"award-number":["Grant award number 2018_03"]}],"id":[{"id":"10.13039\/501100000415","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2026,8,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>It is uncertain whether hyperoxia contributes to adverse intensive care unit outcomes. Potential harm is likely mediated by oxidative stress driving pulmonary and systemic inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a randomised, double-blind, placebo-controlled trial to test the hypothesis that hyperoxia modifies pulmonary and systemic inflammation following inhaled lipopolysaccharide (LPS) challenge. Healthy adult volunteers were randomised (1:1) to receive hyperoxia administered via high-flow nasal oxygen (FiO\n                      <jats:sub>2<\/jats:sub>\n                      1.0, 60\u2009L\/min) or synthetic medical air for 6\u2009hours. Bronchoalveolar lavage (BAL) was performed at 6\u2009hours following inhalation of 50\u2009\u00b5g of LPS. Blood was collected at baseline, 6 hours and 24 hours. The primary outcome was BAL interleukin-8 (IL-8). Secondary outcome measures included markers of pulmonary and systemic inflammation. Untargeted metabolomic and lipidomic profiling of BAL fluid and plasma was performed by liquid chromatography\u2013mass spectrometry to investigate oxidative stress. Transcriptomic analysis was also performed on whole blood.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between January 2023 and March 2024, twenty-two participants were recruited and completed all study procedures. BAL IL-8 did not differ between groups at 6\u2009hours (hyperoxia 375.7\u2009pg\/mL (IQR 351.1\u2013467.7)\u2009vs placebo 331.9\u2009pg\/mL (IQR 251.6\u2013459), p=0.33). No between-group differences were observed in BAL cytokines or markers of systemic inflammation. Hyperoxia was associated with an approximately fourfold increase in BAL reduced glutathione (unadjusted p=0.02). Hyperoxia was associated with distinct transcriptional responses at 24\u2009hours with 175 differentially expressed genes (padj &lt;0.05), including upregulation of genes related to extracellular matrix remodelling, platelet activation and endothelial repair.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>In a human inhaled LPS challenge model, 6\u2009hours of hyperoxia did not increase markers of pulmonary or systemic inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05414370\">NCT05414370<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thorax-2026-225321","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:25:16Z","timestamp":1789061116000},"page":"thorax-2026-225321","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of hyperoxia on pulmonary inflammation and organ injury in a human in vivo model (HIPI): a randomised controlled trial"],"prefix":"10.1136","clinical-trial-number":[{"clinical-trial-number":"nct05414370","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05414370","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0552-1115","authenticated-orcid":false,"given":"Dermot","family":"Linden","sequence":"first","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast, UK"},{"name":"Belfast Health and Social Care Trust, Mater Hospital Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Dorrian","sequence":"additional","affiliation":[{"name":"Belfast Health and Social Care Trust, Mater Hospital Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Glenn","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikha","family":"Tandel","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Mawhinney","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Welzenbach","sequence":"additional","affiliation":[{"name":"Novartis Biomedical Research, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"Rowland","sequence":"additional","affiliation":[{"name":"Novartis Biomedical Research, London, UK"},{"name":"Queen\u2019s University Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[{"name":"Novartis Biomedical Research, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Klein","sequence":"additional","affiliation":[{"name":"Novartis Biomedical Research, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Randazzo","sequence":"additional","affiliation":[{"name":"Novartis Biomedical Research, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Sindelar","sequence":"additional","affiliation":[{"name":"Novartis Biomedical Research, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Schlotterbeck","sequence":"additional","affiliation":[{"name":"Novartis Biomedical Research, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Cattini","sequence":"additional","affiliation":[{"name":"Novartis Biomedical Research, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahilanandan","family":"Dushianthan","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Crossley","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McKelvey","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Bailey","sequence":"additional","affiliation":[{"name":"Belfast Health and Social Care Trust, Mater Hospital Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Conlon","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Carr","sequence":"additional","affiliation":[{"name":"Belfast Health and Social Care Trust, Mater Hospital Belfast, Belfast, UK"},{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Northern Ireland Clinical Research Facility, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Bradley","sequence":"additional","affiliation":[{"name":"Belfast Health and Social Care Trust, Mater Hospital Belfast, Belfast, UK"},{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Northern Ireland Clinical Research Facility, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford C","family":"Taggart","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Simpson","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kidney","sequence":"additional","affiliation":[{"name":"Belfast Health and Social Care Trust, Mater Hospital Belfast, Belfast, UK"},{"name":"Mater Hospital Belfast, HCS Belfast Health and Social Care Trust, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia M","family":"O\u2019Kane","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast, UK"},{"name":"Belfast Health and Social Care Trust, Mater Hospital Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3283-1947","authenticated-orcid":false,"given":"Daniel Francis","family":"McAuley","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast, UK"},{"name":"Regional Intensive Care Unit, HCS Belfast Health and Social Care Trust, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"2026091010251110000_thorax-2026-225321v1.1","doi-asserted-by":"publisher","DOI":"10.1186\/cc7151"},{"key":"2026091010251110000_thorax-2026-225321v1.2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2011-200078"},{"key":"2026091010251110000_thorax-2026-225321v1.3","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198311000-00012"},{"key":"2026091010251110000_thorax-2026-225321v1.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-006-0382-4"},{"key":"2026091010251110000_thorax-2026-225321v1.5","article-title":"Proceedings: Instability of poorly ventilated lung units during oxygen breathing","volume":"242","author":"Dantzker","year":"1974","journal-title":"J Physiol"},{"key":"2026091010251110000_thorax-2026-225321v1.6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/ajplegacy.1947.149.2.277","article-title":"The effect of the inhalation of high and low oxygen concentrations on respiration, pulse rate, ballistocardiogram and arterial oxygen saturation (oximeter) of normal individuals","volume":"149","author":"DRIPPS","year":"1947","journal-title":"Am J Physiol"},{"key":"2026091010251110000_thorax-2026-225321v1.7","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1016\/S0021-9258(19)68544-3","article-title":"Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria","volume":"256","author":"Freeman","year":"1981","journal-title":"J Biol Chem"},{"key":"2026091010251110000_thorax-2026-225321v1.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2012.03774.x"},{"key":"2026091010251110000_thorax-2026-225321v1.9","doi-asserted-by":"publisher","DOI":"10.1007\/PL00007639"},{"key":"2026091010251110000_thorax-2026-225321v1.10","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00308.2009"},{"key":"2026091010251110000_thorax-2026-225321v1.11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.11993"},{"key":"2026091010251110000_thorax-2026-225321v1.12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(17)30046-2","article-title":"Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trial","volume":"5","author":"Asfar","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2026091010251110000_thorax-2026-225321v1.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903297"},{"key":"2026091010251110000_thorax-2026-225321v1.14","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1164\/rccm.202303-0560OC","article-title":"Conservative versus Liberal Oxygenation Targets in Intensive Care Unit Patients (ICONIC): A Randomized Clinical Trial","volume":"208","author":"van der Wal","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026091010251110000_thorax-2026-225321v1.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.9663"},{"key":"2026091010251110000_thorax-2026-225321v1.16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200810-1584OC"},{"key":"2026091010251110000_thorax-2026-225321v1.17","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-208571"},{"key":"2026091010251110000_thorax-2026-225321v1.18","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-210305"},{"key":"2026091010251110000_thorax-2026-225321v1.19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2024-002393","article-title":"Effects of Hyperoxia on Pulmonary Inflammation and organ injury in a human in vivo model (HIPI): study protocol of a randomised, double-blind, placebo-controlled trial","volume":"12","author":"Linden","year":"2025","journal-title":"BMJ Open Resp Res"},{"key":"2026091010251110000_thorax-2026-225321v1.20","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201310-1892OC"},{"key":"2026091010251110000_thorax-2026-225321v1.21","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3393"},{"key":"2026091010251110000_thorax-2026-225321v1.22","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00067.2006"},{"key":"2026091010251110000_thorax-2026-225321v1.23","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.12.3.7873193"},{"key":"2026091010251110000_thorax-2026-225321v1.24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-61489-y","article-title":"Characterization of pulmonary immune responses to hyperoxia by high-dimensional mass cytometry analyses","volume":"10","author":"Hanidziar","year":"2020","journal-title":"Sci Rep"},{"key":"2026091010251110000_thorax-2026-225321v1.25","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M304370200"},{"key":"2026091010251110000_thorax-2026-225321v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(88)80703-0"},{"key":"2026091010251110000_thorax-2026-225321v1.27","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1165\/rcmb.2024-0201OC","article-title":"PD-L1 and PD-1 Are Associated with Clinical Outcomes and Alveolar Immune Cell Activation in Acute Respiratory Distress Syndrome","volume":"71","author":"Morrell","year":"2024","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026091010251110000_thorax-2026-225321v1.28","doi-asserted-by":"publisher","DOI":"10.1378\/chest.100.5.1397"},{"key":"2026091010251110000_thorax-2026-225321v1.29","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00120703"},{"key":"2026091010251110000_thorax-2026-225321v1.30","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/148.5.1174"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2026-225321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:25:18Z","timestamp":1789061118000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2026-225321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":30,"alternative-id":["10.1136\/thorax-2026-225321"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2026-225321","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}